Skip to main content
Clinical Trials/NCT02929108
NCT02929108CompletedNot Applicable

ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision)

Washington University School of Medicine3 sites in 1 country489 target enrollmentStarted: April 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
489
Locations
3
Primary Endpoint
Change in Generalized Anxiety Disorder- 7

Study Overview

Brief Summary

The project will test the effect of educating and supporting family caregivers of hospice cancer patients on their active participation in shared decision making in the plan of care for their patients.

Detailed Description

This intervention will target education and emotional support to family caregivers of hospice cancer patients for a shared decision making process in the hospice care plan meetings The intervention ACCESS will consist of three components:

1: a Facebook group to provide the education and support; 2. web conferencing for family members into the hospice interdisciplinary care plan meeting 3, a structured shared decision making process to guide the team discussion.

Participants (family caregivers) will be randomly assigned to one of three groups, usual care, Facebook only, and Access.

The specific aims are to:

  1. Evaluate the effect of access on family caregiver anxiety, pain knowledge and patient pain.
  2. Evaluate the effect of Facebook groups as educational emotional support for family caregivers
  3. Assess staff and family caregiver satisfaction with the shared decision making process.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Is caregiving for a patient enrolled in the participating hospice
  • •Over 18 years of age
  • •Is caregiving for a patient with a diagnosis of cancer
  • •Willing to have a Facebook account and post at least 1x per week if in intervention group

Exclusion Criteria

  • •No one under the age of 18
  • •Is caregiving for a patient enrolled in hospice agencies other than those participating in the study
  • •Unwilling to participate in social media
  • •Is caregiving for a patient with a diagnosis other than cancer
  • •Is caregiving for a patient with a life expectancy of less than 2 weeks

Arms & Interventions

Enhanced Usual Care

No Intervention

The family caregivers in his group will receive usual hospice care which has been enhanced as the staff have been trained in shared decision making.

Facebook

Experimental

The family caregivers in this group only participates in the Facebook groups, not in the shared decision making

Intervention: Facebook (Behavioral)

ACCESS

Experimental

The family caregivers in this group participates in Facebook and web conferencing for shared decision making

Intervention: Facebook (Behavioral)

ACCESS

Experimental

The family caregivers in this group participates in Facebook and web conferencing for shared decision making

Intervention: ACCESS (Behavioral)

Outcomes

Primary Outcomes

Change in Generalized Anxiety Disorder- 7

Time Frame: Upon enrollment, 14 days, 28 days, 60 days and 90 days

A screening tool to quantify participant's anxiety. The scale ranges from 0-21. A higher score indicates a higher level of anxiety.

Secondary Outcomes

  • Perceived Involvement of Care Scale(Upon enrollment, 14 days, 28 days, and 90 days)
  • Change in Family Pain Questionnaire - Experience(Upon enrollment and 28 days)
  • Change in Family Pain Questionnaire - Knowledge(Upon enrollment and 28 days)
  • Zarit Burden Scale(Upon enrollment and 28 days)
  • Caregiver Communication Questionnaire (CCCQ)(14 days, 28 days, and 60 days)
  • Change in Caregiver Quality of Life(Upon enrollment, 14 days, 28 days, 60 days and 90 days)
  • Edmonton Symptom Assessment(Upon enrollment, 14 days, 28 days, 60 days, and 90 days)
  • Public Health Questionnaire (PHQ 9)(Upon enrollment, 14 days, 28 days, 60 days, and 90 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Debra Parker Oliver

Professor

Washington University School of Medicine

Study Sites (3)

Loading locations...

Similar Trials